Search research articles
Contact Us
Filters
Showing results (121-130 of 391) with videos related to
Page
of 40
Sort By:
Journal of Scleroderma and Related Disorders
|
November 15, 2024
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease
Dinesh Khanna, Luke B Evnin, Shervin Assassi, et al.
Advances in Therapy
|
December 22, 2021
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
Michael Kreuter, Toby M Maher, Tamera J Corte, et al.
Frontiers in Medicine
|
July 5, 2022
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a <i>post-hoc</i> Analysis
Maria Molina-Molina, Michael Kreuter, Vincent Cottin, et al.
Chest
|
April 10, 2025
Effect of Admilparant, an Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary Fibrosis
Michael Kreuter, Toby M Maher, Wim A Wuyts, et al.
Respiratory Research
|
July 5, 2022
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
Toby M Maher, Arnaud Bourdin, Elizabeth R Volkmann, et al.
EJNMMI Physics
|
June 6, 2018
Improved quantitation and reproducibility in multi-PET/CT lung studies by combining CT information
Beverley F Holman, Vesna Cuplov, Lynn Millner, et al.
Lung
|
November 8, 2022
Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done
Kian Fan Chung, Surinder S Birring, Alyn H Morice, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2024
Competing Causes of Death in Idiopathic Pulmonary Fibrosis
Ashwatha Thenappan, Toby M Maher, Leda Yazbeck, et al.
The European Respiratory Journal
|
November 2, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns
Michael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
Thorax
|
April 5, 2017
A lesson in plasticity: a 74-year-old man with plastic bronchitis
Anand Shah, Jackie Donovan, Phil Marino, et al.
Page
of 40
Search research articles
Search
Showing results (121-130 of 391) with videos related to
Sort By:
Page
of 40
Journal of Scleroderma and Related Disorders
|
November 15, 2024
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease
Dinesh Khanna, Luke B Evnin, Shervin Assassi, et al.
Advances in Therapy
|
December 22, 2021
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
Michael Kreuter, Toby M Maher, Tamera J Corte, et al.
Frontiers in Medicine
|
July 5, 2022
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a <i>post-hoc</i> Analysis
Maria Molina-Molina, Michael Kreuter, Vincent Cottin, et al.
Chest
|
April 10, 2025
Effect of Admilparant, an Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary Fibrosis
Michael Kreuter, Toby M Maher, Wim A Wuyts, et al.
Respiratory Research
|
July 5, 2022
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
Toby M Maher, Arnaud Bourdin, Elizabeth R Volkmann, et al.
EJNMMI Physics
|
June 6, 2018
Improved quantitation and reproducibility in multi-PET/CT lung studies by combining CT information
Beverley F Holman, Vesna Cuplov, Lynn Millner, et al.
Lung
|
November 8, 2022
Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done
Kian Fan Chung, Surinder S Birring, Alyn H Morice, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2024
Competing Causes of Death in Idiopathic Pulmonary Fibrosis
Ashwatha Thenappan, Toby M Maher, Leda Yazbeck, et al.
The European Respiratory Journal
|
November 2, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns
Michael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
Thorax
|
April 5, 2017
A lesson in plasticity: a 74-year-old man with plastic bronchitis
Anand Shah, Jackie Donovan, Phil Marino, et al.
Page
of 40